Immunai IPO

Immuani develops solutions for oncology treatments and auto-immune disorders by utilizing AI and ML technology to assist in mapping and to provide insights into the reprogramming of the immune system.

Register for Details

For more details on financing and valuation for Immunai, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Immunai's ticker symbol?

Immunai does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

What is Immunai's stock price?

The stock price for Immunai will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Who are Immunai's major investors?

8VC
Koch Disruptive Technologies
Icon Ventures

Immunai Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
10/27/2021 Series C-1 and C-2 $1.15B $XXX.XX $XXX.XX
2/11/2021 Series B-1 and B-2 $240.97MM $XXX.XX $XXX.XX
5/14/2020 Series A, Seed-1, and Seed-2 $38.16MM $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about Immunai

What is Immunai funding to date?

Immunai has raised $295.22MM with the following series:
$38.16MM for Series A, Seed-1, and Seed-2, $240.97MM for Series B-1 and B-2, $1.15B for Series C-1 and C-2

When was Immunai founded?

Immunai was founded in 2018.

Can you invest in Immunai?

Immunai is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Can you sell Immunai share pre-IPO?

If you own Immunai pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Is Immunai a publicly traded company?

Immunai is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Other companies like Immunai in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$303.94MM
Sector
Last Round Est. Valuation
$298.33MM
Sector
Last Round Est. Valuation
$1.08B
Sector
 
 
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$4.26B